Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
MEDORPHAN 1.5mg/ml syrup.
Pharmaceutical Form |
---|
Syrup. The solution is a slightly yellowish, clear, peach flavored syrup. |
Each ml contains 1.5 mg dextromethorphan hydrobromide.
Excipients with known effect: sucrose, sorbitol, liquid glucose, ethanol and sodium. Each ml contains 325 mg sucrose, 65 mg sorbitol, 395 mg glucose, 50.28 mg ethanol and 0.208 mg sodium.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Demorphan |
Dextromethorphan is a non-opioid antitussive drug. The major metabolite of dextromethorphan, dextrorphan, binds with high affinity to σ-receptors to produce its antitussive activity without exhibiting the classic opiate effects that occur from binding into μ- and δ-receptors. In larger than therapeutic doses, dextrorphan is also an antagonist of N-methyl-D-aspartate (NMDA) receptors. |
List of Excipients |
---|
Saccharin Sodium E954 |
150 ml or 200 ml Type III (Ph.Eur) brown glass bottles closed with one of the following caps:
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
M.L.: 022945
16/05/2019
Drug | Countries | |
---|---|---|
MEDORPHAN | Cyprus |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.